Steven Halper
Stock Analyst at Cantor Fitzgerald
(2.43)
# 2,391
Out of 4,862 analysts
72
Total ratings
51.67%
Success rate
8.98%
Average return
Main Sectors:
Stocks Rated by Steven Halper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NYXH Nyxoah | Reiterates: Overweight | $11 | $7.55 | +45.70% | 5 | Sep 26, 2023 | |
| NNOX Nano-X Imaging | Reiterates: Overweight | $30 | $5.04 | +495.24% | 11 | Sep 26, 2023 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $3.80 | +321.05% | 4 | Sep 14, 2023 | |
| AMWL American Well | Initiates: Overweight | $300 | $6.78 | +4,324.78% | 1 | Sep 14, 2021 | |
| HQY HealthEquity | Maintains: Overweight | $82 → $85 | $104.76 | -18.86% | 10 | Jun 8, 2021 | |
| OMCL Omnicell | Downgrades: Neutral | n/a | $29.25 | - | 7 | Dec 3, 2020 | |
| ROOT Root, Inc. | Initiates: Overweight | $504 | $146.69 | +243.58% | 1 | Nov 23, 2020 | |
| GOCO GoHealth | Initiates: Overweight | $390 | $5.67 | +6,778.31% | 1 | Aug 10, 2020 | |
| EVH Evolent Health | Downgrades: Neutral | $9 → $8 | $8.27 | -3.26% | 6 | Jun 2, 2020 | |
| TDOC Teladoc Health | Maintains: Neutral | $135 → $145 | $6.86 | +2,013.70% | 8 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $150 → $185 | $4.10 | +4,412.20% | 5 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $245 → $255 | $317.40 | -19.66% | 2 | Feb 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $345 → $400 | $235.26 | +70.02% | 2 | Feb 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $25.99 | +23.12% | 1 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $83 | $55.22 | +49.40% | 8 | Dec 17, 2018 |
Nyxoah
Sep 26, 2023
Reiterates: Overweight
Price Target: $11
Current: $7.55
Upside: +45.70%
Nano-X Imaging
Sep 26, 2023
Reiterates: Overweight
Price Target: $30
Current: $5.04
Upside: +495.24%
Health Catalyst
Sep 14, 2023
Reiterates: Overweight
Price Target: $16
Current: $3.80
Upside: +321.05%
American Well
Sep 14, 2021
Initiates: Overweight
Price Target: $300
Current: $6.78
Upside: +4,324.78%
HealthEquity
Jun 8, 2021
Maintains: Overweight
Price Target: $82 → $85
Current: $104.76
Upside: -18.86%
Omnicell
Dec 3, 2020
Downgrades: Neutral
Price Target: n/a
Current: $29.25
Upside: -
Root, Inc.
Nov 23, 2020
Initiates: Overweight
Price Target: $504
Current: $146.69
Upside: +243.58%
GoHealth
Aug 10, 2020
Initiates: Overweight
Price Target: $390
Current: $5.67
Upside: +6,778.31%
Evolent Health
Jun 2, 2020
Downgrades: Neutral
Price Target: $9 → $8
Current: $8.27
Upside: -3.26%
Teladoc Health
Apr 15, 2020
Maintains: Neutral
Price Target: $135 → $145
Current: $6.86
Upside: +2,013.70%
Feb 21, 2020
Reiterates: Overweight
Price Target: $150 → $185
Current: $4.10
Upside: +4,412.20%
Feb 6, 2020
Reiterates: Overweight
Price Target: $245 → $255
Current: $317.40
Upside: -19.66%
Feb 5, 2020
Reiterates: Overweight
Price Target: $345 → $400
Current: $235.26
Upside: +70.02%
Jan 9, 2020
Initiates: Overweight
Price Target: $32
Current: $25.99
Upside: +23.12%
Dec 17, 2018
Maintains: Overweight
Price Target: $73 → $83
Current: $55.22
Upside: +49.40%